Legal & General Group
TENX icon

Legal & General Group’s Tenax Therapeutics TENX Stock Holding History

Legal & General Group’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5K Buy
+2,442
New +$31.2K ﹤0.01% 2891

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Legal & General Group's TENX Position: Q2 2026 in Review

Legal & General Group opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 2,442 shares worth $35.5K. The stake represents ﹤0.01% of the portfolio and ranks #2891 among its holdings.

111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Legal & General Group held 2,442 shares of Tenax Therapeutics worth $35.5K as of Q2 2026.
  • Tenax Therapeutics was a new Legal & General Group position in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2891 holding.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.